会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 22. 发明申请
    • System and method for playing a game of chance having a base game and a bonus game
    • 用于玩基本游戏和奖励游戏的机会游戏的系统和方法
    • US20080102918A1
    • 2008-05-01
    • US11976704
    • 2007-10-26
    • Michael CampagnoJeffrey Schwartz
    • Michael CampagnoJeffrey Schwartz
    • A63F9/24
    • G07F17/3258G07F17/32
    • Embodiments of the invention include method and system for providing a bonus game of chance in conjunction with a plurality of base games of chance over a plurality of gaming locations. The bonus game is associated with a vault including a bonus prize and a secret combination of discrete elements. A player is qualified to participate in the bonus game upon meeting at least one winning criterion on the base game of chance. An input device is provided to be presented to the player, wherein the player inputs a guess at the secret combination. The player guess at the secret combination is then received through the input device and a determination is won as to whether the bonus prize is won based on the secret combination, the player guess, and a matching criteria associated with the secret combination.
    • 本发明的实施例包括用于在多个游戏位置结合多个机会的基本游戏提供机会的奖励游戏的方法和系统。 奖金游戏与包括奖金奖金和离散元素的秘密组合的保险库相关联。 一名玩家有资格参加奖金游戏,符合基本游戏机会的至少一项获胜标准。 提供输入设备以呈现给玩家,其中玩家输入秘密组合的猜测。 然后,通过输入装置接收玩家对秘密组合的猜测,并且基于秘密组合,玩家猜测以及与秘密组合相关联的匹配标准,赢得奖金奖金是否获胜。
    • 25. 发明授权
    • CRF analog conjugates
    • CRF类似物共轭物
    • US5132111A
    • 1992-07-21
    • US508258
    • 1990-04-11
    • Wylie W. Vale, Jr.Jean E. F. RivierJeffrey Schwartz
    • Wylie W. Vale, Jr.Jean E. F. RivierJeffrey Schwartz
    • C07K14/575
    • C07K14/57509Y10S514/805Y10S530/807Y10S930/28
    • Agonists and antagonists of rCRF are disclosed that exhibit good binding affinity to CRF receptors. One exemplary agonist is: H-Ser-Gln-Glu-Pro-Pro-Ile-Ser- Leu-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Met-Leu-Glu-Met- Ala-Arg-Ala-Glu-Gln-Glu-Ala-Glu-Gln-Ala-Ala-Leu-Asn-Arg- Leu-Leu-Leu-Glu-Glu-Ala-NH.sub.2. In the agonists, one or more of the first five N-terminal residues may be deleted or may be substituted by a peptide up to 10 amino acids long. A number of other substitutions may also be made throughout the chain. Similar peptides which function as CRF antagonists are created by deleting the first 7, 8 or 9 N-terminal residues. These analogs are coupled to a cytotoxin, such as gelonin, by a dialdehyde or the like, e.g., glutaraldehyde. The conjugates may be used to eliminate CRF Target Cells, and thus to regulate secretion of ACTH, .beta.-lipotropin and the like. Such conjugates can also be administered to alleviate conditions associated with hyperactivity of the hypothalamus-pituitary adrenal axis as well as neoplastic diseases associated with tumors that express CRF receptor.
    • 公开了rCRF的激动剂和拮抗剂,其表现出对CRF受体的良好结合亲和力。 一个示例性的激动剂是:H-Ser-Gln-Glu-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Met-Leu-Glu-Met- -Arg-Ala-Glu-Gln-Glu-Ala-Glu-Gln-Ala-Ala-Leu-Asn-Arg-Leu-Leu-Leu-Glu-Glu-Ala-NH2。 在激动剂中,前5个N-末端残基中的一个或多个可以被缺失,或者可被长达10个氨基酸的肽取代。 还可以在整个链中进行许多其它取代。 作为CRF拮抗剂起作用的相似肽通过缺失第7,8或9个N-末端残基而产生。 这些类似物通过二醛或类似物例如戊二醛与细胞毒素(例如gelonin)偶联。 缀合物可用于消除CRF靶细胞,并因此调节ACTH,β-Lipotropin等的分泌。 也可以施用这样的缀合物以减轻与下丘脑 - 垂体肾上腺轴的多动症相关的病症以及与表达CRF受体的肿瘤相关的肿瘤疾病。